Related Experiment Video
Updated: Jun 24, 2026

Oropharyngeal Administration of Bleomycin in the Murine Model of Pulmonary Fibrosis
Published on: May 9, 2025
[ARDS--pulmonary repair and therapeutic options]
Stephan Urs Sixt1, Michael Adamzik, Jürgen Peters
1Klinik für Anästhesiologie und Intensivmedizin, Universitätsklinikum Essen der Universität Duisburg-Essen. anaesthesixt@gmx.de
Acute Respiratory Distress Syndrome (ARDS) involves lung injury and fibrosis. This review covers recent advances in lung repair mechanisms, cellular and genetic factors influencing ARDS severity and survival.
Area of Science:
- Pulmonary Medicine
- Pathology
- Genetics
Background:
- Acute Respiratory Distress Syndrome (ARDS) is a severe lung condition.
- It involves inflammation, pulmonary edema, and lung tissue injury.
- Fibrosis is a key feature impacting survival.
Purpose of the Study:
- To review recent advances in ARDS research.
- Focus on fibroproliferation, lung repair mechanisms, and genetic factors.
- Understand factors influencing ARDS severity and patient survival.
Main Methods:
- Literature review of recent scientific publications.
- Analysis of cellular and soluble factors in lung repair.
- Examination of genetic influences on ARDS outcomes.
Main Results:
- Recent advances in understanding fibroproliferation pathways.
- Identification of key cellular and soluble mediators.
- Insights into genetic predispositions and their impact on ARDS.
Conclusions:
- Lung repair is crucial for ARDS survival.
- Fibroproliferation, cellular, soluble, and genetic factors are critical targets.
- Further research can improve ARDS treatment and outcomes.
Related Concept Videos
Pneumothorax-II
Clinical Manifestations:
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Pulmonary Cycle: Exhalation
Flail Chest-II
Assessment:
1. Clinical Evaluation:
History:
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
